Navigation Links
Clinical Trials for a Low-dose Steroid Therapy for Bone Marrow Cancer Prove Positive

Researchers see hopes in a new therapy combining low dose steroid with lenalidomide, already// found effective against multiple myeloma.

Multiple myeloma is a cancer of plasma cells that are found in blood and bone marrow.

Survival chances improved considerably when a low dose of the steroid dexamethasone combined with lenalidomide was tried on patients with newly diagnosed multiple myeloma.

The clinical trial was sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and conducted by a network of researchers led by the Eastern Cooperative Oncology Group (ECOG).

The significance of the results lies in that a low dose regimen has been found to be more effective than the standard dose of dexamethasone.

Researchers found that patients in the study who received a lower dose regimen had a one-year survival of 96 percent compared to 86 per cent for patients treated in the case of those with the standard-dose of dexamethasone and lenalidomide.

In addition, there were fewer side effects associated with the low-dose dexamethasone and lenalidomide.

"These results have major implications for myeloma therapy," noted study chair Vincent Rajkumar. "The results of this study, particularly lenalidomide plus low-dose dexamethasone, are very positive and in my opinion represent a real step forward in the treatment of this disease."

The application of this effective and less toxic approach is expected to benefit many patients with myeloma.

In 2007, an estimated 19,900 people in the United States will be diagnosed with multiple myeloma and an estimated 10,790 people will die of the disease.
SRM
'"/>




Page: 1

Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
(Date:5/23/2012)... the American Health Care System was released by Foundation ... predecessor, the second edition textbook offers a comprehensive vision ... U.S. health care system. Law and the American Health ... in how health care is organized, financed, and delivered. ... on how a dramatically changing legal environment influencesand in ...
(Date:5/23/2012)... (HealthDay News) -- New research suggests that young asthma ... such as ipratropium [Atrovent] -- could be more likely ... However, the increased risk was not seen ... raises concern because of the recent interest in use ... the University of Illinois at Chicago, said in a ...
(Date:5/23/2012)... SAN FRANCISCO A tiny, resilient metal wire designed ... relief to patients with severe heterogeneous emphysema, a subtype ... of the lungs, according to the results of a ... France. The wire, called a lung volume reduction coil ... take the place of more invasive procedures used to ...
(Date:5/22/2012)... are critical for determining effectiveness of medical therapies, ... for these studies compared with other western countries, ... Canadian Medical Association Journal ). , Dr. Salim ... Ontario, with Dr. John Cairns, University of British ... Canada should provide better financial support of clinical ...
(Date:5/22/2012)... itself with the daunting challenge of bringing mobility ... to a child in a developing country is ... engagement versus no societal engagement and individual freedom ... the Mercyhurst University Institute for Public Health, who ... to Guanajuato, Mexico, with a team of students, ...
Breaking Medicine News(10 mins):Health News:Landmark textbook on health care and the US legal system released 2Health News:Asthma Meds May Be Linked to Irregular Heartbeat 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 2Health News:Tiny implanted coil improves lung function in patients with severe emphysema 3Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:New initiative aims to increase mobility for disabled children worldwide 2
... pill, which rescues many women from unwanted pregnancies can ... sex. These findings were released after a study conducted ... at the University of Montreal in Quebec, Canada, and ... of the American Journal of Obstetrics and Gynecology, and ...
... affected country by the AIDS virus, HIV, is in an ... positive. If this isn’t enough, the government is in the ... consignment of one million AIDS detecting kits free of cost ... the South African president Thabo Mbeki caused a flutter when ...
... Corp. and Health South Corp. together will build ... a release on Monday, issued by the out ... feature inpatient beds with display screens connected to ... and a wireless communications network permitting doctors and ...
... uncomfortable questions and more troubling answers is that of drug ... has kindled a lot of heated arguments for and against ... most when it comes to drug testing when sometimes very ... in the name of conducting a study.,A new Harris interactive ...
... survey said that of all ailments people are most worried ... read something on heart disease, they get so engrossed in ... based on the assumption that it could lead to heart ... infections can predispose to heart problems. This will make many ...
... Throwing their lot with the group of scientists asking for more ... a letter to U.S. President George W. Bush asking him not ... stem cell research is reaching a feverish pitch with both sides ... research. While those who oppose it call the research as immoral, ...
Other Medicine News:
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
... than 70 abstracts highlight VELCADE efficacy in broad ... CAMBRIDGE, Mass., June 19, 2007 /PRNewswire-FirstCall/ --,Millennium Pharmaceuticals, ... leading therapy with unsurpassed single-agent,efficacy for patients with ... the upcoming International Myeloma,Workshop (IMW) in Kos, Greece, ...
... Describes Identification, Characterization and Broad,Neuroprotective Properties of ... , Neurodegenerative Disease Specialists Publish Details of ... Mitochondrial Proteins , MARSEILLE, June 19th, 2007 ... the discovery and development of drugs for,neurological ...
Other Medicine Technology:Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4
... Transfer an Entire Column of a ... efficiency and throughput with 384 well plates, you ... narrow well spacing. Thats exactly what you get ... or Impact2 software (see Impact/Impact2), this innovation was ...
... an Entire Column of a 384 Well Plate ... with 384 well plates, you need a pipettor ... Thats exactly what you get with our 16-channel ... (see Impact/Impact2), this innovation was specifically designed to ...
... The Seal-Away CS and ... are designed for the introduction ... the coronary sinus from a ... St. Jude Medical's outstanding peel-away ...
... is the world leader in peel-away ... worldwide for permanent pacemaker and defibrillator ... port implantation, and for temporary pacemaker ... Jude Medical Peel-Away introducers includes the ...
Medicine Products: